Table 1.
Mutant frequency in the cII gene in liver lobes of DMN- and furan-treated Big Blue B6C3F1 female micea.
Treatment | Average (×10−5) ± SD | N | |
---|---|---|---|
Positive controlb | Control | 0.9 ± 0.5 | 5 |
DMN | 3.0 ± 0.5c | 5 | |
Six-week experimentd | Control | 1.2 ± 0.3 | 3 |
Furan | 1.2 ± 0.2 | 5 | |
Three-week experimente | Control | 1.8 ± 0.5 | 5 |
Furan | 1.1 ± 0.2 | 5 |
Data for individual animals are displayed in Supplemental Tables 1–3 and were corrected for the percentage of clonal mutants, with the exception of the DMN-treated group and its control.
Groups of five female mice were given four doses of 0 or 4 mg/kg DMN in saline by oral gavage for 4 consecutive days. Mice were sacrificed 10 days after final treatment.
Statistically different from controls, p-value < 0.0003.
Groups of five mice were given 0 or 15 mg/kg bw furan in corn oil by oral gavage on 5 days per week for 6 weeks. Mice were sacrificed 24 h after the final dose.
Groups of five mice were given 0 or 15 mg/kg bw furan in corn oil by oral gavage once weekly for 3 weeks. Mice were sacrificed 1 week after the final dose.